Pfizer (PFE) Tops Q4 EPS by 28c, Tops on Revenue; Offers Guidance
Tweet
Share
E-mail
Get Alerts PFE Hot Sheet
Price: $26.87 +0.30%
Financial Fact:
Cash dividends paid per common share (in dollars per share): 0.3
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Cash dividends paid per common share (in dollars per share): 0.3
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Pfizer (NYSE: PFE) reported Q4 EPS of $0.10, $0.28 better than the analyst estimate of ($0.18). Revenue for the quarter came in at $14.25 billion versus the consensus estimate of $14.22 billion.
The company reaffirms Full-Year 2024 guidance provided on December 13, 2023, of Revenues of $58.5 to $61.5 Billion and Adjusted Diluted EPS of $2.05 to $2.25
For earnings history and earnings-related data on Pfizer (PFE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
- Four Tree Island Advisory calls DoubleDown $11.25 offer too low
- Is Treasury selloff a major issue for stock market bulls?
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
